Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Proliferative Diabetic Retinopathy(NPDR)”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableStudy completedNCT04636307
What this trial is testing

Characterization of Retinal Disease Progression in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures (CHART)

Who this might be right for
NPDR - Non Proliferative Diabetic RetinopathyDiabetes Mellitus, Type 2Retinal Disease
Association for Innovation and Biomedical Research on Light and Image 202
Testing effectiveness (Phase 2)Ended earlyNCT02681809
What this trial is testing

Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR

Who this might be right for
Diabetic RetinopathyPosterior Vitreous DetachmentDisease Progression
ThromboGenics 48
Very early researchNot Yet RecruitingNCT07198815
What this trial is testing

A Preliminary Exploratory Clinical Trial to Evaluate the Efficacy of NPDR-01 Eye Drops in the Treatment of Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Diabetic Retinal MicroangiopathyRetinal Microaneurysms+1 more
Sichuan Academy of Medical Sciences 10
Early research (Phase 1)Study completedNCT06487845
What this trial is testing

Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Who this might be right for
Chronic Kidney DiseaseNon-proliferative Diabetic RetinopathyHealthy Volunteers
Bayer 24
Testing effectiveness (Phase 2)Study completedNCT06599684
What this trial is testing

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic Retinopathy+2 more
Invirsa, Inc. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Post-approval studies (Phase 4)Study completedNCT07230184
What this trial is testing

To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
AJU Pharm Co., Ltd. 52
Large-scale testing (Phase 3)Study completedNCT02718326
What this trial is testing

Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)

Who this might be right for
Nonproliferative Diabetic Retinopathy
Regeneron Pharmaceuticals 402
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Testing effectiveness (Phase 2)Study completedNCT01571232
What this trial is testing

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaNon-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Retina Macula Institute 20
Not applicableStudy completedNCT03696810
What this trial is testing

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Who this might be right for
NPDR - Non Proliferative Diabetic Retinopathy
Association for Innovation and Biomedical Research on Light and Image 141
Testing effectiveness (Phase 2)Looking for participantsNCT06770933
What this trial is testing

Evaluate the Efficacy and Safety of Orally Administered VX-01

Who this might be right for
Diabetic RetinopathyNPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd 100
Large-scale testing (Phase 3)Study completedNCT00130845
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 312
Not applicableStudy completedNCT01145599
What this trial is testing

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Who this might be right for
Type 2 DiabetesNon Proliferative Diabetic Retinopathy
European Vision Institute Clinical Research Network 374
Testing effectiveness (Phase 2)Looking for participantsNCT07354477
What this trial is testing

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)Open-angle Glaucoma (OAG)Normal Tension Glaucoma (NTG)
Qlaris Bio, Inc. 14
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Not applicableUnknownNCT04103671
What this trial is testing

Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Non Proliferative Diabetic Retinopathy
Zhongshan Ophthalmic Center, Sun Yat-sen University 272
Large-scale testing (Phase 3)Enrolling By InvitationNCT06951087
What this trial is testing

Intravitreal and Intracameral DEX in NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Affiliated Hospital of Nantong University 80
Load More Results